Commentary · 2 Dec 2025
Mini reviewPublished 27 Feb 2021
Emerging Medicines in Multiple Sclerosis
Department of Biotechnology, Kakatiya University, Warangal, Telangana, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Multiple sclerosis (MS) is a progressive autoimmune neurological condition that mostly affects young adults and may be debilitating. Multiple sclerosis (MS) is currently treated with a number of disease-modifying medications (DMDs) (MS). There has been a surge in the discovery and advancement of possible novel drugs for MS, including oral therapies, in recent years. The aim of this review is to provide concise information on the mechanism of action, signs, symptoms, diagnosis as well as new therapies and medications that may be used off-label in MS.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Neuroinfectious Diseases.
Commentary · 1 Dec 2025
Central Nervous System Opportunistic Infections: Diagnosis and Management
Opinion · 1 Dec 2025
Cerebrospinal Fluid Biomarkers For Neurological Disease Diagnosis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Neuroinfectious Diseases
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Kommu Santhosh”
